PKSI-527 is a new, highly selective plasma kallikrein inhibitor . PKSI-527 can suppress collagen-induced arthritis (CIA) by modifying the kallikrein-kinin system.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Kallikrein
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.